| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |